<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24173191</article-id>
      <article-id pub-id-type="pmc">3798362</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132054</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Non-cultured melanocyte/keratinocyte transplantation for the treatment of
stable vitiligo on the face: report of two cases<sup><xref ref-type="fn" rid="fn03">*</xref></sup></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Transplante de suspens&#xE3;o celular de melan&#xF3;citos/queratin&#xF3;citos para o
tratamento de vitiligo est&#xE1;vel na face: relato de dois casos</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Mariana Gontijo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Daniel Gontijo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gontijo</surname>
            <given-names>Gabriel</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Camila Gontijo</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rocha</surname>
            <given-names>Tania Nely</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rocha</surname>
            <given-names>Rafael Henrique</given-names>
          </name>
          <xref ref-type="aff" rid="aff06">6</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> PhD in Immunology from the Federal University of Minas Gerais
(Universidade Federal de Minas Gerais - UFMG) - Adjunct Professor Professor of
Immunology - Belo Horizonte (MG), Brazil.</aff>
      <aff id="aff02"><label>2</label> Preceptor of Surgical Dermatology at the Charity Hospital of Belo
Horizonte (Santa Casa de Miseric&#xF3;rdia de Belo Horizonte) - Belo Horizonte (MG),
Brazil.</aff>
      <aff id="aff03"><label>3</label> Master's Degree in Dermatology from the Federal University of Minas
Gerais (Universidade Federal de Minas Gerais - UFMG) - Professor of Dermatology and
preceptor of Dermatological Surgery at the Federal University of Minas Gerais
(Universidade Federal de Minas Gerais - UFMG) - Belo Horizonte (MG), Brazil.</aff>
      <aff id="aff04"><label>4</label> Physical therapist - Belo Horizonte (MG), Brazil.</aff>
      <aff id="aff05"><label>5</label> Dermatologist - Specialist in dermatology from the University of the
State of Rio de Janeiro (Universidade do Estado do Rio de Janeiro - UERJ); Graduate work
in integrative psychotherapy from the Institute for Integrative Psychotherapy -
USA.</aff>
      <aff id="aff06"><label>6</label> MD - Degree in medicine from the Medical Sciences School of Minas
Gerais (Faculdade de Ci&#xEA;ncias M&#xE9;dicas de Minas Gerais - FCMMG) - Belo Horizonte (MG),
Brazil.</aff>
      <author-notes>
        <corresp id="c01"> MAILING ADDRESS: Mariana Gontijo Ramos, Pra&#xE7;a da Bandeira, 170, 4&#xBA;
andar - Mangabeiras. 30130-050 - Belo Horizonte - MG, Brazil, E-mail:
<email>ramosbh@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>5</issue>
      <fpage>811</fpage>
      <lpage>813</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>There are many alternatives to treat vitiligo, including surgical procedures, which
are recommended for patients resistant to other therapies. The
melanocyte/keratinocyte transplantation consists in the separation of epidermal cells
obtained from a donor site and spreading these cells on the depigmented and
dermabraded recipient area. Two patients were submitted to transplantation, showing
more than 70% repigmentation in the treated areas after four months, both with
excellent degree of satisfaction. The method requires some laboratory skills, but
represents a simple and safe procedure.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Existem v&#xE1;rias alternativas para o tratamento do vitiligo, incluindo procedimentos
cir&#xFA;rgicos, que s&#xE3;o indicados para pacientes refrat&#xE1;rios aos outros tipos de
tratamento. O transplante de suspens&#xE3;o celular de melan&#xF3;citos/queratin&#xF3;citos consiste
na separa&#xE7;&#xE3;o de c&#xE9;lulas da epiderme obtidas de &#xE1;rea doadora, e aplica&#xE7;&#xE3;o destas
c&#xE9;lulas na &#xE1;rea receptora despigmentada, ap&#xF3;s dermoabras&#xE3;o. Dois pacientes com
vitiligo est&#xE1;vel foram submetidos ao transplante de suspens&#xE3;o de
melan&#xF3;citos/queratin&#xF3;citos, apresentando repigmenta&#xE7;&#xE3;o acima de 70% nas &#xE1;reas
tratadas ap&#xF3;s quatro meses, ambos com excelente grau de satisfa&#xE7;&#xE3;o. O m&#xE9;todo requer
alguma habilidade laboratorial, mas representa um procedimento simples e seguro.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Melanocytes</kwd>
        <kwd>Transplantation</kwd>
        <kwd>Vitiligo</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Vitiligo is a dyschromia marked by the onset of procedures. Patients who are resistant
to other treatlesions of different shapes and sizes, as a result of mela-ments may
benefit from surgical treatments, which connocyte destruction. It affects men and women
of sist in transplantation of cutaneous tissue or cell susvarious ethnic groups equally,
reaching around 2% of pension applied to the affected areas.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> The method of the global population.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup>
There are several therapeutic non-cultured melanocytes/keratinocytes (melanocyte
alternatives for the treatment of vitiligo, including topi-cell suspension)
transplantation consists in the separacal and oral agents, phototherapy, laser and
surgical tion of epidermal cells from a donor site and their application to depigmented
recipient areas. The results depend on some factors such as the shape and stability of
vitiligo, phototype and anatomic location of lesions.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <sec>
        <title>Methodology</title>
        <p>The patients selected for transplantation presented vitiligo with a minimum stability
of one year. The technique used was described by Mulekar in 2005.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> The donor site (upper thigh region)
was anesthetized and a thin skin layer was removed by shaving with a flexible blade
(Crystalia), placed on a Petri dish containing 0.2% trypsin solution (Cultilab) and
incubated for 30 minutes at 37&#xBA;C. After washing with DMEM/F-12 medium (Cultilab) the
epidermis was separated from the dermis, fragmented into smaller pieces, transferred
to a tube containing the same medium and centrifuged for 6 min. at 2000 rpm. The cell
pellet was resuspended in an 1 mL syringe. The recipient area was submitted to
low-speed dermabrasion. The cell suspension was then uniformly spread and the area
was covered with a collagen dressing (Neuskin-F, Medira, UK) and Tegaderm. The
patient was discharged and the dressing removed after one week. Only one session was
carried out with each patient.</p>
      </sec>
      <sec>
        <title>Case 1</title>
        <p>A male patient, 41 years old, driver. Previously submitted to surgical reconstruction
and insertion of a prosthesis to replace the eye lost in an automobile accident.
After the surgery, he noticed the onset of a depigmented macule in the periorbital
region, which was diagnosed as localized segmental vitiligo. Topical treatment was
started with corticosteroids, viticromin and excimer laser (17 sessions), with
discreet improvement (5%). He was referred for melanocyte transplantation, which was
performed on the lesion in the left periorbital region (<xref ref-type="fig" rid="f01">Figure 1A</xref>). Two months after the transplant a 60% improvement in
repigmentation was observed during patient assessment and photographic evidence
(<xref ref-type="fig" rid="f01">Figure 1B</xref>). Four months later there was an
increase in repigmentation (75%) of the treated area, resulting in an excellent
degree of patient satisfaction (<xref ref-type="fig" rid="f01">Figure 1C</xref>).</p>
        <fig id="f01" orientation="portrait" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p><bold>A.</bold> Vitiligo lesion on the periorbital region before
transplantation of melanocyte suspension; <bold>B.</bold> Vitiligo lesion on
the periorbital region two months after transplantation of melanocyte
suspension; C. Vitiligo lesion on the periorbital region four months after
transplantation of melanocyte suspension</p>
          </caption>
          <graphic xlink:href="abd-88-05-0811-g01"/>
        </fig>
      </sec>
      <sec>
        <title>Case 2</title>
        <p>A male patient, 35 years old, presented generalized acrofacial vitiligo, with several
lesions on the hands, feet and frontal region. A previous treatment with psoralene
and sun exposure did not improve lesions significantly. He was submitted to
melanocyte suspension transplantation for treatment of frontal region lesions (<xref ref-type="fig" rid="f02">Figure 2A</xref>). Three months later a 90% improvement
in repigmentation was observed, measured by photographic assessment, with excellent
uniformity of color (<xref ref-type="fig" rid="f02">Figure 2B</xref>). The patient
demonstrated a high degree of satisfaction and desire to have further transplant
sessions to treat other affected areas.</p>
        <fig id="f02" orientation="portrait" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p>A. Vitiligo lesion on the forehead region before transplantation of melanocyte
suspension; B. Vitiligo lesion on the forehead region four months after
transplantation of melanocyte suspension</p>
          </caption>
          <graphic xlink:href="abd-88-05-0811-g02"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Surgical procedures for stable vitiligo may be an alternative for patients that did not
respond to prior therapy. The transplantation of melanocyte/keratinocyte suspension
allows the treatment of larger depigmented areas in practically any anatomic region,
removing a relatively small and very thin skin graft from the donor site, which rarely
results in hypertrophic or unaesthetic scars.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Dermabrasion of the recipient area is a simple, superficial and
safe procedure. There is no risk of a hypochromic halo, nor of a cobblestone aspect or
necrosis. The procedure may be used to treat challenging places such as eyelids,
fingers, articulations and lips.<sup><xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>Results using this technique or similar ones have been achieved by different authors.
Olsson and Juhlin (1998) managed to reach 100% repigmentation in 3 patients with
segmental vitiligo and 78% in 20 patients with generalized vitiligo.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> A satisfactory response was also observed
by Mulekar (2005) in patients with different forms of disease onset; the highest
percentage (95%) was found in patients with segmental vitiligo and the lowest in
generalized vitiligo.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Paul (2011)
verified that 65% of the patients with segmental vitiligo presented over 90%
repigmentation and Huggins and collaborators (2012) demonstrated more abundant
repigmentation in patients with segmental vitiligo and less in generalized
vitiligo.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Neves and
collaborators (2010) observed progressive repigmentation with 90% improvement in
achromic lesion in the pretibial region after 3 sessions of melanocyte transplantation
using the punch grafting technique.<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
Machado-Filho and collaborators (2005) demonstrated moderate to intense degree of
pigmentation on vitiligo lesions, by means of a curettage grafting method.<sup><xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>In the cases reported by our group it was possible to observe excellent responses, which
were expected in case 1, localized vitiligo, but also in case 2, acrofacial generalized
vitiligo, suggesting good response in facial localization even for more refractory forms
of vitiligo.</p>
      <p>Vitiligo stability seems to be the most important parameter to be considered for the
performance of any melanocyte transplantation technique in the treatment of
vitiligo.<sup><xref ref-type="bibr" rid="r10">10</xref></sup> Other factors, such
as the type of vitiligo, location and patient phototype also influence the response. The
indication and selection of patients to undergo this procedure should be carefully done.
In the reported cases, the transplantation was carried out without complications before
or after surgery, in both patients. The healing process of the donor site was good and
there was no depigmentation. Both patients presented good response to treatment, with a
repigmentation rate above 70% and high overall satisfaction with the results of the
procedure. The melanocyte cell suspension transplantation seems to be an important tool
for the treatment of vitiligo in patients that do not respond to conventional non
surgical treatments. In most cases, repigmentation takes place in 2 to 4 months,
uniformly and with a similar color to the original skin. Patients with segmental or
focal vitiligo are the ones that benefit the most from this method, which requires some
laboratory skills but represents an efficient, simple and safe procedure.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn03" fn-type="other">
        <p>* Study carried out at the Cl&#xED;nica Gabriel Gontijo de Dermatologia - Belo Horizonte
(MG), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nunes</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Esser</surname>
              <given-names>SMH</given-names>
            </name>
          </person-group>
          <article-title>Epidemiological profile of vitiligo patients and its association with
thyroid disease</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>241</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">21603806</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Majid</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Imran</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Ultrathin split-thickness grafting followed by narrowband UVB therapy
for stable vitiligo: An effective and cosmetically satisfying
option</article-title>
          <source>Indian Dermatol Venereol Leprol</source>
          <year>2012</year>
          <volume>78</volume>
          <fpage>159</fpage>
          <lpage>164</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rusfianti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wirohadidjodjo</surname>
              <given-names>YW</given-names>
            </name>
          </person-group>
          <article-title>Dermatosurgical techniques for repigmentation of
vitiligo</article-title>
          <source>Int J Dermatol</source>
          <year>2006</year>
          <volume>45</volume>
          <fpage>411</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">16650168</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mulekar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Long-term follow-up study of 142 patients with vitiligo vulgaris
treated by autologous, non-cultured melanocyte-keratinocyte cell
transplantation</article-title>
          <source>Int J Dermatol</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>841</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="pmid">16207186</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huggins</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Mulekar</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Ozog</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Jabobsen</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Melanocyte-keratinocyte transplantation procedure in the treatment of
vitiligo: The experience of an academic medical center in the United
States</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2012</year>
          <volume>66</volume>
          <fpage>785</fpage>
          <lpage>793</lpage>
          <pub-id pub-id-type="pmid">21864935</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paul</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Autologous non-cultured basal cell-enriched Epidermal Cell Suspension
transplantation in vitiligo: Indian Experience</article-title>
          <source>J Cutan Aesthet Surg</source>
          <year>2011</year>
          <volume>4</volume>
          <fpage>23</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">21572677</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Juhlin</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Leukoderma treated by transplantation of a basal cell layer enriched
suspension</article-title>
          <source>Br J Dermatol</source>
          <year>1998</year>
          <volume>138</volume>
          <fpage>644</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="pmid">9640371</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neves</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>R&#xE9;gis</surname>
              <given-names>JR</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>PJV</given-names>
            </name>
            <name>
              <surname>Zac</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Melanocyte transplant in piebaldism - Case report</article-title>
          <source>An Bras Dermatol</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>384</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">20676476</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machado-Filho</surname>
              <given-names>CDS</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Proto</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Landman</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Vitiligo: analysis of grafting versus curettage alone, using
melanocyte morphology and reverse transcriptase polymerase chain reaction for
tyrosinase mRNA</article-title>
          <source>Sao Paulo Med J.</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>187</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">16389417</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dinda</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Study of clinical, biochemical and immunological factors determining
stability of disease in patients with generalized vitiligo undergoing melanocyte
transplantation</article-title>
          <source>Br J Dermatol</source>
          <year>2012</year>
          <volume>166</volume>
          <fpage>1230</fpage>
          <lpage>1236</lpage>
          <pub-id pub-id-type="pmid">22329760</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
